Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENSIFENTRINE vs EPCORITAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENSIFENTRINE vs EPCORITAMAB: Safety Overview

Metric ENSIFENTRINE EPCORITAMAB
Total FAERS Reports 410 2,041
Deaths Reported 2 430
Death Rate 0.5% 21.1%
Hospitalizations 77 1,652
Average Patient Age 71.7 yrs 67.5 yrs
% Female Patients 51.6% 47.5%
FDA Approval Date Jun 26, 2024 N/A
Manufacturer Verona Pharma, Inc. Genmab US, Inc.
Route RESPIRATORY (INHALATION) SUBCUTANEOUS
Marketing Status Prescription N/A